CytomX Therapeutics, Inc. (CTMX) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 3.94 and resistance around 4.63. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 6.33, so a violation there would materially change the current setup narrative.

📊 Technical Summary

CytomX Therapeutics, Inc. (CTMX) closed at 4.22 (+4.20%). Price is trading below the 50-day average but still above the 200-day average, which points to medium-term softness inside a still constructive longer-term structure. 20-day momentum is running at -7.46%, with price remains inside its roughly 52-week range (0.74–6.75), while ATR14 volatility is elevated at roughly 6.45% of price. RSI(14) is 42.7, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. From a pattern perspective, the main active signal is Double top. The nearest decision zone is framed by support at 3.94 and resistance at 4.63. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Revenue: 5.96M · Net income: -14.23M. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more